Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00190905 · ClinicalTrials.gov registry record · Phase 4
Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.
A Phase 4 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 4
- Development phase
- 4,000
- Enrollment target
NCT00190905 is a Phase 4 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 4,000 participants.
The verdict
NCT00190905, a Phase 4 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 4,000 participants
- Enrollment target
Study Summary
The purpose of the trial is to study the safety and effectiveness of duloxetine HCl in women of different backgrounds with stress urinary incontinence who may also have other various medical conditions.
Interventions
- DRUG duloxetine HCl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2004-02 |
| Est. Completion | 2005-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00190905
The ClinicalTrials.gov registry entry for NCT00190905 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which duloxetine HCl is the first listed.
NCT00190905 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00190905 about?
NCT00190905 is a clinical study titled "Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.". The purpose of the trial is to study the safety and effectiveness of duloxetine HCl in women of different backgrounds with stress urinary incontinence who may also have other various medical conditions.
What is the current status of trial NCT00190905?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 4,000 participants. The study started on 2004-02. Estimated completion is 2005-07.
What interventions are being tested in trial NCT00190905?
The interventions under investigation include: duloxetine HCl (DRUG).
Who is sponsoring clinical trial NCT00190905?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.